If I were Cytodyn exec management team , once I looked at the mortality, and it turned out to be favorable , I would put out a press release early. I would say something to the effect of “ on xxxx day we unblinded our date from cd12. We performed an initial review and are optimistic that the data may provide the world with a drug to use for emergency use to help curb the death rate caused by this global pandemic “

The lawyers of course would need to review this . So a couple of points. It doesn’t say anything specifically about the FDA approving it which means he wouldn’t be passing off the FDA for squeezing them in the corner. It leaves the door open for a possible no go from the fda but more than likely , approvals from countries which have lower bars for EUA than the US . Again, only if the primary endpoint looks good...